Cardiovascular

Latest News

Gaps in the Coordination of Care for Older Adults With or at Risk for Cardiovascular Disease

By Lisa M. Kern, MD, MPH
Joselyne E. Aucapina

June 3rd 2025

Older adults with cardiovascular disease (CVD) or CVD risk factors report that gaps in communication among their providers are common and hazardous.

CBD oils and hemp leaves | Image credit: Irina_Evva – stock.adobe.com

CBD-Based Drug Shows No Heart Safety Risks in Patients With CVD or Risk Factors

By Hayden E. Klein

May 23rd 2025

Predicting Mortality Risk Using the PREVENT Equation Across Diverse Racial Groups

By Ofer Kobo, MD
Martin K. Rutter, MD

May 16th 2025

Doctor taking child's blood pressure | Image credit: romaset – stock.adobe.com

3 Maternal Risk Factors Linked to Elevated Offspring Blood Pressure

By Hayden E. Klein

May 14th 2025

Nurse using stethoscope on older patient | Image credit: InsideCreativeHouse – stock.adobe.com

Is Frailty Index the Most Accurate Predictor of CVD?

By Hayden E. Klein

May 9th 2025

Lipoprotein(a) and Cardiovascular Risk

Learn about more about lipoprotein(a), including how to improve patient outcomes through better screening and management.

Watch Now

Continuing Medical Education

View All

June 4th 2025

Exploring Transthyretin-Mediated Amyloidosis and Its Phenotypes: A Comprehensive Approach to Patient Treatment

1.5 Credits / Cardiology, Neurology, Rare Diseases

June 4th 2025

The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation

1 Credit / Cardiology, Neurology

June 4th 2025

Evidence-Based Guidelines Point to Leap in Care for Hypertrophic Cardiomyopathy

1.0 Credit / Cardiology

More News

April 13th 2017

Lipid Management: Coverage Criteria vs FDA Labeling

April 13th 2017

Coverage of Statins/Nonstatins in Lipid Management

April 13th 2017

Cholesterol Goals in Primary Cardiovascular Disease Prevention

April 13th 2017

Early Detection of Risk and Familial Hypercholesterolemia

April 13th 2017

Managed Care Decision Making in CVD and Lipid Control

April 13th 2017

Current CVD Prevention and Management Challenges

April 6th 2017

Dr Janet Wright Discusses How Million Hearts Will Leverage Partnerships for Success

The Million Hearts initiative, which aims to prevent a million cardiovascular events in a 5-year period, will focus on utilizing its partnerships with health systems and employers as it embarks upon its second phase, according to Janet Wright, MD, FACC, the program’s executive director.

March 30th 2017

Cardiovascular Outcome Trials: How Misinterpretation of Statistics Can Affect Clinical Practice

Michael R. Page, PharmD, RPh

At the Academy of Managed Care Pharmacy Annual Meeting in Denver, Colorado, Kevin C. Maki, PhD, CLS, FNLA, FTOS, FACN, of Midwest Biomedical Research/Center for Metabolic and Cardiovascular Health in Chicago, Illinois, discussed methods of quantifying treatment effects in cardiovascular outcomes trials.

March 30th 2017

Dr Clifford Goodman Outlines Takeaways From a Health Economic Case Study on Repatha

During an industry workshop at the Academy of Managed Care Pharmacy Annual Meeting in Denver, Colorado, Cliff Goodman, PhD, of the Lewin Group, moderated a session that provided a health economic case study on cardiovascular outcome data for Repatha (evolocumab), the PCSK9 inhibitor from Amgen.

March 28th 2017

Dr Alex C. Spyropoulos Discusses the Patient-Centered Directions of Rivaroxaban Research

According to Alex C. Spyropoulos, MD, FACP, FCCP, FRCPC, professor of medicine at the Hofstra Northwell School of Medicine, research on rivaroxaban to prevent thrombosis is moving from determining efficacy to evaluating patient-centered outcomes in a variety of clinical situations, as evidenced by new studies like EINSTEIN-CHOICE and the MARINER trial.

March 20th 2017

Dr Jim McDermott Discusses Objectives and Outcomes of CVD-REAL Trial

The CVD-REAL study presented at the American College of Cardiology 66th Scientific Session asked whether cardiovascular outcomes seen in the EMPA-REG OUTCOME trial could be seen in a real-world environment, and for the entire class of SGLT2 inhibitors, according to AstraZeneca’s Jim McDermott, PhD, vice president for Medical Affairs, Diabetes.

March 20th 2017

Dr Janet Wright Outlines Goals and Roadblocks of Million Hearts Initiative

The Million Hearts initiative launched in 2012 set a lofty goal of preventing 1 million cardiovascular deaths in 5 years, but did not quite achieve that target. According to the program’s executive director, Janet Wright, MD, FACC, Million Hearts will continue to make progress in part due to the solid foundations it has formed in the initial stage.

March 17th 2017

Women Taking Statins Faced Increased Diabetes Risk

AJMC Staff

The study found a "dose effect" in the elderly women who took statins to treat cholesterol.

March 16th 2017

Seniors Are Living Longer, Thanks to Medicare Part D

Mary Caffrey

The drop in mortality was driven by a significant drop in cardiovascular mortality, the leading cause of death among seniors.

March 11th 2017

Unmet Needs in Cardiovascular Risk Reduction

March 9th 2017

Marijuana Use Linked to High Risk of Heart Failure, Stroke

Christina Mattina

Researchers have identified another high associated with marijuana use: the risk of heart failure and cerebrovascular accidents.

February 15th 2017

In Light of SPRINT, How to Treat Hypertension?

Mary Caffrey

An author in JAMA points out some caveats to a ground-breaking trial.

February 4th 2017

FOURIER Study Finds Repatha Reduces Risk of Cardiovascular Events

Laura Joszt, MA

Amgen's Repatha was shown to reduce the risk of cardiovascular events, such as cardiovascular death and myocardial infarction, in phase 3 of the FOURIER study. Full results will be presented in March 2017 at the American College of Cardiology 66th Scientific Sessions.

January 31st 2017

AHA Calls for Timing Meals to Lower Cardiovascular Risk

Mary Caffrey

Busy lifestyles are eroding the lines of traditional meal times, and all-day eating is bad for cardiovascular health, the statement says.

January 17th 2017

What's as Bad for the Heart as Obesity? Try Depression

Mary Caffrey

The study found only tobacco use and hypertension were worse on the heart than depression.

January 16th 2017

Safety of Januvia in Oldest Patients With Diabetes Confirmed in Study

Mary Caffrey

The new study in Diabetes Care comes more than a year after the initial results of the TECOS trial were presented at the American Diabetes Association Scientific Sessions.

December 2nd 2016

Jardiance Gets CV Indication for Adults With Type 2 Diabetes

Mary Caffrey

Researchers considered finding a diabetes drug that also produced a cardiovascular benefit to be a "holy grail."

November 21st 2016

Intarcia Submits New Drug Application to FDA for Diabetes Treatment

Mary Caffrey

The matchstick-size pump has been heralded as a game changer in addressing the biggest problem in diabetes care: medication adherence.

November 14th 2016

Could Vectra DA Test Be Used to Predict Cardiovascular Risk?

Patients who live with rheumatoid arthritis do not die from swollen joints but face twice the risk of suffering a heart attack or stroke.

October 26th 2016

Long-Term Exposure to Pollution Linked to Heart Disease

AJMC Staff

A new study suggests pollution particles could set into motion events like heart attacks and strokes years before they occur.

October 5th 2016

Fear of Job Loss Increases Risk of Diabetes, Study Finds

AJMC Staff

While the researchers found a "modest risk" of diabetes associated with job insecurity, they said it pointed to the need for policies that promoted job stability and better wages.

October 3rd 2016

Higher Heart Rate Linked to Increased Mortality, Hospitalization Among African Americans

Mary Caffrey

The Jackson Heart Study continues to yield insights about the nature of cardiovascular disease in minority populations.

September 27th 2016

Therapeutics Issue of Evidence-Based Diabetes Management Takes on Cost, Coverage, and Combinations

Whether it’s the high cost of insulin or the question of when to start combination therapy, the new issue of Evidence-Based Diabetes Management, a publication of The American Journal of Managed Care, covers up-to-the-minute topics in this special issue on therapeutics. Editor-in-chief Robert A. Gabbay, MD, PhD, FACP, leads off this issue featuring voices of providers, pharmaceutical leaders, payers, and patients.

September 23rd 2016

Peer Exchange: As Trials Show CV Benefits in Therapy, Panelists Discuss "Exciting Time" in Diabetes Care

Andrew Smith

Second of 2 Parts: See Part 1, in Evidence-Based Diabetes Management, coverage of Patient-Centered Diabetes Care 2016.

September 16th 2016

Novo's Semaglutide Reduces CV Risk, but Shows More Retinopathy Complications

Mary Caffrey

Results for Novo Nordisk’s semaglutide were reported today at the European Association for the Study of Diabetes. A filing for FDA approval is expected before the end of the year.

...

14 15 16 17 18 19 20 21 22

...

24 >